chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Myalgia, Pain, Peripheral swelling, Tenderness
Clinical narrative: Left arm is slightly swollen; Tender; Problems with my left shoulder; pain; Left arm ahs been sore off and on ever since/arm is still sore to touch/Where I had the shot and below/down into the muscle below also and the area below; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Left arm is slightly swollen), TENDERNESS (Tender), MUSCULOSKELETAL DISCOMFORT (Problems with my left shoulder), PAIN (pain) and MYALGIA (Left arm ahs been sore off and on ever since/arm is still sore to touch/Where I had the shot and below/down into the muscle below also and the area below) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Coagulation disorder. Concurrent medical conditions included Celiac disease (An immune disorder.).   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced MYALGIA (Left arm ahs been sore off and on ever since/arm is still sore to touch/Where I had the shot and below/down into the muscle below also and the area below). On an unknown date, the patient experienced PERIPHERAL SWELLING (Left arm is slightly swollen), TENDERNESS (Tender), MUSCULOSKELETAL DISCOMFORT (Problems with my left shoulder) and PAIN (pain). At the time of the report, PERIPHERAL SWELLING (Left arm is slightly swollen), TENDERNESS (Tender), MUSCULOSKELETAL DISCOMFORT (Problems with my left shoulder), PAIN (pain) and MYALGIA (Left arm ahs been sore off and on ever since/arm is still sore to touch/Where I had the shot and below/down into the muscle below also and the area below) outcome was unknown.            No concomitant product was provided by the reporter. No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Sep-2021: Non significant follow-up received and includes no new information.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Dyspnoea, Electrocardiogram, Fatigue, Hypersomnia
Clinical narrative: Received Pfizer as 1st and 2nd dose; Experiences shortness of breathing; Extreme exhaustion; Fever for 1 day only (about 104F).; Slept for 36 hours / barely stay awake and sleeps for 18 hours a day; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st and 2nd dose), HYPERSOMNIA (Slept for 36 hours / barely stay awake and sleeps for 18 hours a day), DYSPNOEA (Experiences shortness of breathing), PYREXIA (Fever for 1 day only (about 104F).) and FATIGUE (Extreme exhaustion) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    Concurrent medical conditions included Lactose intolerant. Concomitant products included BUPROPION, MELATONIN, PARACETAMOL (TYLENOL A), TILACTASE (LACTASE PLUS), VITAMIN D NOS, MULTIVITAMIN [VITAMINS NOS], PANTOPRAZOLE and COLESEVELAM HYDROCHLORIDE (WELCHOL) for an unknown indication.   On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On 19-Aug-2021, the patient experienced HYPERSOMNIA (Slept for 36 hours / barely stay awake and sleeps for 18 hours a day). On 20-Aug-2021, the patient experienced PYREXIA (Fever for 1 day only (about 104F).). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st and 2nd dose), DYSPNOEA (Experiences shortness of breathing) and FATIGUE (Extreme exhaustion). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st and 2nd dose) had resolved and HYPERSOMNIA (Slept for 36 hours / barely stay awake and sleeps for 18 hours a day), DYSPNOEA (Experiences shortness of breathing), PYREXIA (Fever for 1 day only (about 104F).) and FATIGUE (Extreme exhaustion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104f (High) 104F. On an unknown date, Electrocardiogram: normal (normal) Normal.         Biomarkers were came normal.  Adderall 5mg and Suppressant drugs were used by patient as concomitant medications
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, Pyrexia
Clinical narrative: Received Pfizer as 1st and 2nd dose; Experiences shortness of breathing; Extreme exhaustion; Fever for 1 day only (about 104F).; Slept for 36 hours / barely stay awake and sleeps for 18 hours a day; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st and 2nd dose), HYPERSOMNIA (Slept for 36 hours / barely stay awake and sleeps for 18 hours a day), DYSPNOEA (Experiences shortness of breathing), PYREXIA (Fever for 1 day only (about 104F).) and FATIGUE (Extreme exhaustion) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    Concurrent medical conditions included Lactose intolerant. Concomitant products included BUPROPION, MELATONIN, PARACETAMOL (TYLENOL A), TILACTASE (LACTASE PLUS), VITAMIN D NOS, MULTIVITAMIN [VITAMINS NOS], PANTOPRAZOLE and COLESEVELAM HYDROCHLORIDE (WELCHOL) for an unknown indication.   On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On 19-Aug-2021, the patient experienced HYPERSOMNIA (Slept for 36 hours / barely stay awake and sleeps for 18 hours a day). On 20-Aug-2021, the patient experienced PYREXIA (Fever for 1 day only (about 104F).). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st and 2nd dose), DYSPNOEA (Experiences shortness of breathing) and FATIGUE (Extreme exhaustion). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st and 2nd dose) had resolved and HYPERSOMNIA (Slept for 36 hours / barely stay awake and sleeps for 18 hours a day), DYSPNOEA (Experiences shortness of breathing), PYREXIA (Fever for 1 day only (about 104F).) and FATIGUE (Extreme exhaustion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104f (High) 104F. On an unknown date, Electrocardiogram: normal (normal) Normal.         Biomarkers were came normal.  Adderall 5mg and Suppressant drugs were used by patient as concomitant medications
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose - received 3 weeks after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose - received 3 weeks after 1st dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy since an unknown date. Concurrent medical conditions included Breast cancer stage IV.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose - received 3 weeks after 1st dose). In March 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose - received 3 weeks after 1st dose) had resolved.            Concomitant medication was not provided.  Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node swollen the size of a golf ball; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node swollen the size of a golf ball) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concomitant products included AMITRIPTYLINE and PROPRANOLOL for Migraine, FLUOXETINE HYDROCHLORIDE (PROZAC) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced LYMPHADENOPATHY (Lymph node swollen the size of a golf ball). At the time of the report, LYMPHADENOPATHY (Lymph node swollen the size of a golf ball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication use was reported.   This case was linked to MOD-2021-313320 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was a little sore after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore after the first dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy and Asthma.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm was a little sore after the first dose) (seriousness criterion hospitalization). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore after the first dose) outcome was unknown.      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.  Company comment: This case concerns a 41 year-old, female subject, who experienced the unexpected event of pain in extremity. The event occurred on the same day after the first dose of Spikevax. The rechallenge was not applicable, as the event happened after the first dose. The benefit-risk relationship of Spikevax is not affected by this report.  Company Comment: This case concerns a 41 year-old, female subject, who experienced the unexpected event of pain in extremity. The event occurred on the same day after the first dose of Spikevax. The rechallenge was not applicable, as the event happened after the first dose. The benefit-risk relationship of Spikevax is not affected by this report.   This case was linked to MOD-2021-313196 (Patient Link).; Sender's Comments: This case concerns a 41 year-old, female subject, who experienced the unexpected event of pain in extremity. The event occurred on the same day after the first dose of Spikevax. The rechallenge was not applicable, as the event happened after the first dose. The benefit-risk relationship of Spikevax is not affected by this report.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm  which was hurting; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (arm  which was hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lymphoedema.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm  which was hurting). At the time of the report, PAIN IN EXTREMITY (arm  which was hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: got shingles 3 days after the getting the first caccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (got shingles 3 days after the getting the first vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (got shingles 3 days after the getting the first vaccine). At the time of the report, HERPES ZOSTER (got shingles 3 days after the getting the first vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.   No relevant concomitant medications was reported. Treatment information was not provided.   Reporter did not allow further contact
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Disorientation, Feeling abnormal, Gait disturbance
Clinical narrative: Muscle weakness; Can not remember things; Postural instability; Disorientation; Feeling malaise; Brain fog; Imbalance while walking; getting up;  going up the stairs.; Becoming more irritable; Sick for the last 13 days; Chills; This spontaneous case was reported by a consumer and describes the occurrence of Muscle weakness, Can not remember things, Postural instability, Disorientation, and malaise in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Leukemia and Immunocompromised. Concomitant products included IMBRUVICA for Leukemia, VITAMINS for an unknown indication.    On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced Muscle weakness, Can not remember things, Postural instability, Disorientation, malaise, Brain fog, Imbalance while walking, getting up, and going up the stairs, irritability, Sick for the last 13 days, and Chills. The patient was treated with TYLENOL at an unspecified dose and frequency. At the time of the report, Muscle weakness, Can not remember things, Postural instability, Disorientation, malaise, Brain fog, Imbalance while walking, getting up, and going up the stairs, irritability, Sick for the last 13 days, and Chills outcome was unknown.            Concomitant medications also included problem medicine.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Irritability, Malaise, Memory impairment, Muscular weakness
Clinical narrative: Muscle weakness; Can not remember things; Postural instability; Disorientation; Feeling malaise; Brain fog; Imbalance while walking; getting up;  going up the stairs.; Becoming more irritable; Sick for the last 13 days; Chills; This spontaneous case was reported by a consumer and describes the occurrence of Muscle weakness, Can not remember things, Postural instability, Disorientation, and malaise in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Leukemia and Immunocompromised. Concomitant products included IMBRUVICA for Leukemia, VITAMINS for an unknown indication.    On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced Muscle weakness, Can not remember things, Postural instability, Disorientation, malaise, Brain fog, Imbalance while walking, getting up, and going up the stairs, irritability, Sick for the last 13 days, and Chills. The patient was treated with TYLENOL at an unspecified dose and frequency. At the time of the report, Muscle weakness, Can not remember things, Postural instability, Disorientation, malaise, Brain fog, Imbalance while walking, getting up, and going up the stairs, irritability, Sick for the last 13 days, and Chills outcome was unknown.            Concomitant medications also included problem medicine.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Fatigue, Irritability, Mood swings
Clinical narrative: Lack of energy; Irritable; Moody; loose stools; Tired, Exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Lack of energy), IRRITABILITY (Irritable), MOOD SWINGS (Moody), DIARRHOEA (loose stools) and FATIGUE (Tired, Exhaustion) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cerebral palsy.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, the patient experienced DIARRHOEA (loose stools) and FATIGUE (Tired, Exhaustion). On an unknown date, the patient experienced ASTHENIA (Lack of energy), IRRITABILITY (Irritable) and MOOD SWINGS (Moody). At the time of the report, ASTHENIA (Lack of energy), IRRITABILITY (Irritable) and MOOD SWINGS (Moody) outcome was unknown, DIARRHOEA (loose stools) had resolved and FATIGUE (Tired, Exhaustion) had not resolved.            No concomitant information was reported. No treatment information was reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: pain in left arm; redness in left arm; swelling in left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left arm), ERYTHEMA (redness in left arm) and PERIPHERAL SWELLING (swelling in left arm) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (aspirin ), Drug allergy (ibuprofen ), Drug allergy (hydrocloroquine ), Drug allergy (chloroquine ) and Drug allergy (hydroxychloroquine ). Concomitant products included VITAMIN D [VITAMIN D NOS] and IRON for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in left arm), ERYTHEMA (redness in left arm) and PERIPHERAL SWELLING (swelling in left arm). At the time of the report, PAIN IN EXTREMITY (pain in left arm), ERYTHEMA (redness in left arm) and PERIPHERAL SWELLING (swelling in left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient applied ice to alleviate the events.   This case was linked to MOD-2021-313202 (Patient Link).
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine dose administered after 24 hours at room temperature; The vial was kept at room temperature 69-72 degrees F in the clinic from September 2, 2021 at 9 am to September 3, 2021 at 3:45 pm; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine dose administered after 24 hours at room temperature) and PRODUCT STORAGE ERROR (The vial was kept at room temperature 69-72 degrees F in the clinic from September 2, 2021 at 9 am to September 3, 2021 at 3:45 pm) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included AMLODIPINE and LISINOPRIL for Hypertension.    On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine dose administered after 24 hours at room temperature) and PRODUCT STORAGE ERROR (The vial was kept at room temperature 69-72 degrees F in the clinic from September 2, 2021 at 9 am to September 3, 2021 at 3:45 pm). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine dose administered after 24 hours at room temperature) and PRODUCT STORAGE ERROR (The vial was kept at room temperature 69-72 degrees F in the clinic from September 2, 2021 at 9 am to September 3, 2021 at 3:45 pm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2021: Follow up received includes Added Patient demographic details, other relevant history, Added dose number of suspect, Concomitant medications,  Added new event.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Radiculitis brachial, Vaccination site reaction
Clinical narrative: Parsonage Turner Syndrome; Pain down through the upper arm/Arm problem; COVID Arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RADICULITIS BRACHIAL (Parsonage Turner Syndrome), PAIN IN EXTREMITY (Pain down through the upper arm/Arm problem) and VACCINATION SITE REACTION (COVID Arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RADICULITIS BRACHIAL (Parsonage Turner Syndrome), PAIN IN EXTREMITY (Pain down through the upper arm/Arm problem) and VACCINATION SITE REACTION (COVID Arm). At the time of the report, RADICULITIS BRACHIAL (Parsonage Turner Syndrome), PAIN IN EXTREMITY (Pain down through the upper arm/Arm problem) and VACCINATION SITE REACTION (COVID Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment information was reported by reporter.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID 19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID 19). At the time of the report, COVID-19 (COVID 19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by reporter  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired covid vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired covid vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired covid vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired covid vaccine) had resolved.            Relevant concomitant medications were not reported.  The reporter stated that the vaccine the vaccine was out of refrigerator for days.  The treatment information was  not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Hypersensitivity, Nasal congestion, Oropharyngeal pain
Clinical narrative: congestion; sore throat; allergic reaction to her first dose of Moderna Covid-19 Vaccine; coughing caused by sinus drainage; low grade fever; pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage) and PYREXIA (low grade fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage), PYREXIA (low grade fever) and HEADACHE (pounding headache). At the time of the report, NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage), PYREXIA (low grade fever) and HEADACHE (pounding headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant included allergy medication when required. No treatment was reported by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: congestion; sore throat; allergic reaction to her first dose of Moderna Covid-19 Vaccine; coughing caused by sinus drainage; low grade fever; pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage) and PYREXIA (low grade fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage), PYREXIA (low grade fever) and HEADACHE (pounding headache). At the time of the report, NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage), PYREXIA (low grade fever) and HEADACHE (pounding headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant included allergy medication when required. No treatment was reported by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Arm; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Sore Arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included HRT since an unknown date. Concurrent medical conditions included Asthma chronic. Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore Arm). At the time of the report, VACCINATION SITE PAIN (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was mentioned as patient took HRT. No treatment information was reported. Case is non-serious, no CC is required.   This case was linked to MOD-2021-313517 (Patient Link).; Sender's Comments: Case is non-serious, no CC is required.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lethargy, Myalgia, Pyrexia, Vaccination site erythema
Clinical narrative: fever; ache; sore arm; sore arm, red; arm swollen; lethargic; sore arm, hot; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), VACCINATION SITE WARMTH (sore arm, hot), PYREXIA (fever), MYALGIA (ache) and VACCINATION SITE PAIN (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE and LISINOPRIL for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced LETHARGY (lethargic), VACCINATION SITE WARMTH (sore arm, hot), VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (sore arm, red) and VACCINATION SITE SWELLING (arm swollen). On 21-Aug-2021, the patient experienced PYREXIA (fever) and MYALGIA (ache). On 22-Aug-2021, LETHARGY (lethargic), VACCINATION SITE WARMTH (sore arm, hot), PYREXIA (fever), MYALGIA (ache), VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (sore arm, red) and VACCINATION SITE SWELLING (arm swollen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, Body temperature: 101 (High) Body temperature 101 and 101 (High) Body temperature 101. On 21-Aug-2021, Body temperature: 99-99.5 (High) Body temperature 99-99.5. On 22-Aug-2021, Body temperature: 101 Body temperature 101.         Reportedly, Patient did not visit Healthcare Professional. He stated that when his fever was high he was afraid to visit Hospital due to COVID-19.  Treatment product information was not provided.   This case was linked to MOD-2021-294106 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: fever; ache; sore arm; sore arm, red; arm swollen; lethargic; sore arm, hot; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), VACCINATION SITE WARMTH (sore arm, hot), PYREXIA (fever), MYALGIA (ache) and VACCINATION SITE PAIN (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE and LISINOPRIL for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced LETHARGY (lethargic), VACCINATION SITE WARMTH (sore arm, hot), VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (sore arm, red) and VACCINATION SITE SWELLING (arm swollen). On 21-Aug-2021, the patient experienced PYREXIA (fever) and MYALGIA (ache). On 22-Aug-2021, LETHARGY (lethargic), VACCINATION SITE WARMTH (sore arm, hot), PYREXIA (fever), MYALGIA (ache), VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (sore arm, red) and VACCINATION SITE SWELLING (arm swollen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, Body temperature: 101 (High) Body temperature 101 and 101 (High) Body temperature 101. On 21-Aug-2021, Body temperature: 99-99.5 (High) Body temperature 99-99.5. On 22-Aug-2021, Body temperature: 101 Body temperature 101.         Reportedly, Patient did not visit Healthcare Professional. He stated that when his fever was high he was afraid to visit Hospital due to COVID-19.  Treatment product information was not provided.   This case was linked to MOD-2021-294106 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Hypoaesthesia
Clinical narrative: Weird transient numbness in his extremities (hand and feet) primarily on his left side; Chest tightness when laying down sometimes; Weird kind of cramp on his left side; Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued; Fever; Chills; Body aches; Headache; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Weird transient numbness in his extremities (hand and feet) primarily on his left side), CHEST DISCOMFORT (Chest tightness when laying down sometimes), MUSCLE SPASMS (Weird kind of cramp on his left side), FATIGUE (Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued) and PYREXIA (Fever) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced HYPOAESTHESIA (Weird transient numbness in his extremities (hand and feet) primarily on his left side), CHEST DISCOMFORT (Chest tightness when laying down sometimes), MUSCLE SPASMS (Weird kind of cramp on his left side), FATIGUE (Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, HYPOAESTHESIA (Weird transient numbness in his extremities (hand and feet) primarily on his left side), CHEST DISCOMFORT (Chest tightness when laying down sometimes), MUSCLE SPASMS (Weird kind of cramp on his left side), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown and FATIGUE (Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued) had not resolved.            No concomitant product use was provided by the reporter.   No treatment medications were reported.    This case was linked to MOD-2021-313471 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Weird transient numbness in his extremities (hand and feet) primarily on his left side; Chest tightness when laying down sometimes; Weird kind of cramp on his left side; Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued; Fever; Chills; Body aches; Headache; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Weird transient numbness in his extremities (hand and feet) primarily on his left side), CHEST DISCOMFORT (Chest tightness when laying down sometimes), MUSCLE SPASMS (Weird kind of cramp on his left side), FATIGUE (Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued) and PYREXIA (Fever) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced HYPOAESTHESIA (Weird transient numbness in his extremities (hand and feet) primarily on his left side), CHEST DISCOMFORT (Chest tightness when laying down sometimes), MUSCLE SPASMS (Weird kind of cramp on his left side), FATIGUE (Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, HYPOAESTHESIA (Weird transient numbness in his extremities (hand and feet) primarily on his left side), CHEST DISCOMFORT (Chest tightness when laying down sometimes), MUSCLE SPASMS (Weird kind of cramp on his left side), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown and FATIGUE (Fatigue/fatigue has been kind of lingering/it is over a week now and he's still fatigued) had not resolved.            No concomitant product use was provided by the reporter.   No treatment medications were reported.    This case was linked to MOD-2021-313471 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Sep-2021 and was forwarded to Moderna on 09-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Chills, Cold sweat, Fatigue
Clinical narrative: clamminess; looks awful / feels awful; headache; she couldn't sleep; fever; whole body aches; chills; fatigue; abdominal cramping; Migraines; weakness; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines) and ASTHENIA (weakness) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines), ASTHENIA (weakness), PYREXIA (fever), MYALGIA (whole body aches), CHILLS (chills) and FATIGUE (fatigue). On an unknown date, the patient experienced COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), INSOMNIA (she couldn't sleep) and HEADACHE (headache). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) for Adverse event, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA-SELTZER) for Adverse event, at a dose of UNK, bid. At the time of the report, COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines), ASTHENIA (weakness), INSOMNIA (she couldn't sleep), PYREXIA (fever), HEADACHE (headache), MYALGIA (whole body aches), CHILLS (chills) and FATIGUE (fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Doctor prescribed a headache medicine.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Insomnia, Migraine, Myalgia
Clinical narrative: clamminess; looks awful / feels awful; headache; she couldn't sleep; fever; whole body aches; chills; fatigue; abdominal cramping; Migraines; weakness; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines) and ASTHENIA (weakness) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines), ASTHENIA (weakness), PYREXIA (fever), MYALGIA (whole body aches), CHILLS (chills) and FATIGUE (fatigue). On an unknown date, the patient experienced COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), INSOMNIA (she couldn't sleep) and HEADACHE (headache). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) for Adverse event, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA-SELTZER) for Adverse event, at a dose of UNK, bid. At the time of the report, COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines), ASTHENIA (weakness), INSOMNIA (she couldn't sleep), PYREXIA (fever), HEADACHE (headache), MYALGIA (whole body aches), CHILLS (chills) and FATIGUE (fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Doctor prescribed a headache medicine.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: clamminess; looks awful / feels awful; headache; she couldn't sleep; fever; whole body aches; chills; fatigue; abdominal cramping; Migraines; weakness; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines) and ASTHENIA (weakness) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines), ASTHENIA (weakness), PYREXIA (fever), MYALGIA (whole body aches), CHILLS (chills) and FATIGUE (fatigue). On an unknown date, the patient experienced COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), INSOMNIA (she couldn't sleep) and HEADACHE (headache). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) for Adverse event, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA-SELTZER) for Adverse event, at a dose of UNK, bid. At the time of the report, COLD SWEAT (clamminess), FEELING ABNORMAL (looks awful / feels awful), ABDOMINAL PAIN (abdominal cramping), MIGRAINE (Migraines), ASTHENIA (weakness), INSOMNIA (she couldn't sleep), PYREXIA (fever), HEADACHE (headache), MYALGIA (whole body aches), CHILLS (chills) and FATIGUE (fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Doctor prescribed a headache medicine.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Got Covid-19 between 1st and 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Got Covid-19 between 1st and 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got Covid-19 between 1st and 2nd dose). At the time of the report, COVID-19 (Got Covid-19 between 1st and 2nd dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.